|
|
Other links at Articles > Business of Medicine |
| 1. |
Health Net Cuts Outlook Again, Shares Fall
|
|
|
Health insurer Health Net Inc cut its full-year forecast significantly on Tuesday for the second time since April, blaming higher patient costs and enrollment losses due to the weakening U.S. economy, and its shares fell 16 percent. Reuters Health Information
|
| 2. |
Galvus Gets Positive EU Opinion
|
|
|
Galvus (vildagliptin; Novartis), a dipeptidyl peptidase-IV (DPP-IV) inhibitor that improves cell responsiveness to glucose, has received a positive opinion from European health authorities after the firm made changes to prescribing recommendations due to liver safety concerns. Reuters Health Information
|
| 5. |
FDA Approves Test for Hepatitis B Viral Load
|
|
|
The US Food and Drug Administration has approved the first nucleic acid test for hepatitis B virus that measures blood levels of viral DNA as an estimate of viral load. Medscape Medical News
|
|
|